Recruiting
Phase 1

Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy

Sponsor:

National Institute of Neurological Disorders and Stroke (NINDS)

Code:

NCT05849467

Conditions

Multiple Sclerosis

Progressive Multifocal Leukoencephalopathy

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

89 Zr-Df-crefmirlimab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information